SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-004476
Filing Date
2022-01-07
Accepted
2022-01-07 16:21:54
Documents
12
Period of Report
2022-01-04
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d263094d8k.htm   iXBRL 8-K 24977
  Complete submission text file 0001193125-22-004476.txt   154795

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20220104.xsd EX-101.SCH 2887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20220104_lab.xml EX-101.LAB 19655
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20220104_pre.xml EX-101.PRE 12311
6 EXTRACTED XBRL INSTANCE DOCUMENT d263094d8k_htm.xml XML 3593
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 22518404
SIC: 2836 Biological Products, (No Diagnostic Substances)